Dng m su, ci thin da kh rp, xn mu
Malhotra D, Saxena AK, Dar SA, Kumar V, Nasare N, Tripathi AK, Banerjee BD
Duration: Usually resolves within 6 to 12 months, even if treatment continues
Recognizing deficiency symptoms and understanding who is at increased risk can help guide the decision-making process
In particular, compared to the mild degeneration group, the expression levels of ferroptosis driver genes ( ACSL4 , SLC39A14 , and CHAC1 ) were relatively higher in the severe degeneration group, whereas the expression levels of ferroptosis suppressor genes ( GPX4 , FTH1 , and HSPB1 ) were significantly lower (Fig
Ideally, a second independent study would replicate the findings to strengthen confidence in the conclusions